Cardiol Therapeutics Inc. (CRDL) Debt by Year
Cardiol Therapeutics Inc. held $15.6M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Cardiol Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CRDL Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CRDL Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Cardiol Therapeutics Inc. financials
Frequently Asked Questions
What was Cardiol Therapeutics Inc.'s long-term debt in fiscal year 2025?
Cardiol Therapeutics Inc. held $15.6M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Cardiol Therapeutics Inc. (CRDL) reported on that line in every period on record.